Back to Resource Library
JBTS

Joubert Syndrome

Overview

Joubert syndrome is a rare autosomal recessive ciliopathy defined by the pathognomonic 'molar tooth sign' on brain MRI (cerebellar vermis hypoplasia with elongated superior cerebellar peduncles), hypotonia, developmental delay, and oculomotor apraxia. Retinal dystrophy (Leber congenital amaurosis-like) occurs in ~30% of patients and is a major cause of visual impairment. Over 40 causative genes have been identified, all encoding proteins of the primary cilium or basal body.

Genetics

Genetically heterogeneous with 40+ causative genes. CEP290 is the most common gene associated with retinal involvement. All inheritance is autosomal recessive.

GeneLocusInheritanceNotes
CEP29012q21.32ARMost common gene with retinal involvement; also causes LCA10
TMEM678q22.1ARMeckelin; associated with liver/kidney involvement
CC2D2A4p15.32ARCoiled-coil and C2 domain-containing protein 2A
AHI16q23.3ARAbelson helper integration site 1; cerebellar vermis hypoplasia
INPP5E9q34.3ARInositol polyphosphate-5-phosphatase E

Clinical Presentation

Neonatal/Infancy

  • Hypotonia
  • Oculomotor apraxia
  • Episodic hyperpnea/apnea

Childhood

  • Developmental delay and intellectual disability
  • Ataxia
  • Retinal dystrophy in ~30%

Variable

  • Renal disease (nephronophthisis) in some
  • Liver fibrosis in some
  • Polydactyly in some

Diagnosis

  • Brain MRI: Molar tooth sign — pathognomonic
  • ERG: Cone-rod or rod-cone dystrophy if retinal involvement
  • Genetic testing: Comprehensive ciliopathy gene panel
  • Renal ultrasound: Nephronophthisis screening
  • Developmental assessment: Cognitive and motor evaluation

Current Research & Treatment

No disease-modifying treatments approved. CEP290-targeted antisense oligonucleotide therapy (sepofarsen) for the LCA10 mutation is relevant for patients with CEP290-JBTS retinal involvement. Ciliopathy research is advancing rapidly with multiple gene therapy programs in development.

Active Clinical Trials

The following active clinical trials are investigating treatments for Joubert Syndrome. Trial status and enrollment may change; always verify directly on ClinicalTrials.gov.

Disclaimer: ClearSight is not affiliated with any clinical trial sponsor or organization. Trial information is sourced from ClinicalTrials.gov and public press releases for educational purposes only. Always consult a qualified healthcare professional before considering trial participation.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Genetic testing and clinical management should be performed by qualified healthcare professionals, including ophthalmologists and genetic counselors.